GBA1 Gene (Glucosylceramidase Beta 1)

GBA1: A key gene in Gaucher disease, Parkinson's disease, and lysosomal function.

Gene Information Card

Symbol GBA1
Full Name Glucosylceramidase Beta 1
Gene Type Protein coding
Chromosomal Location 1q22
NCBI Gene ID 2629 ncbi.nlm.nih.gov/gene/2629
Ensembl ID ENSG00000177628
UniProt ID P04062
OMIM ID 606463
HGNC ID 4177
Aliases GBA, GCB, GLUC, GBA1A, GBA1B

Description

The GBA1 gene encodes the lysosomal enzyme glucocerebrosidase (also known as beta-glucocerebrosidase). This enzyme catalyzes the hydrolysis of glucocerebroside to glucose and ceramide. Mutations in GBA1 cause Gaucher disease, the most common lysosomal storage disorder, and are a major genetic risk factor for Parkinson's disease and Lewy body dementia.

Disease Associations

Disease category Pathophysiological mechanism Genomic evidence
Gaucher disease (type 1, 2, 3) Loss-of-function mutations in GBA1 lead to accumulation of glucocerebroside in macrophages, causing organomegaly, bone lesions, and neurological symptoms. OMIM #230800, #230900, #231000
Parkinson's disease Heterozygous GBA1 mutations increase risk (odds ratio ~5) via lysosomal dysfunction and alpha-synuclein accumulation. ClinVar, PMID: 19597539
Lewy body dementia GBA1 variants are associated with increased risk and earlier onset of dementia with Lewy bodies. ClinVar, PMID: 26940714

Expression Profile

Tissue Expression
Tissue nTPM level
Spleen 45.2 High
Liver 32.1 High
Lung 18.5 Medium
Brain (cerebellum) 12.3 Medium
Heart 8.9 Low
Cell Line Expression
Cell Line nTPM Notes
HEK 293 35.0 High expression
HepG2 28.4 High expression
SH-SY5Y 15.2 Moderate expression
K562 22.1 High expression
Data source:Human Protein Atlas(proteinatlas.org)

Mutations & Variants

Hotspot Mutations
Variant Type Frequency Functional Description
c.1226A>G (p.Asn409Ser) Missense ~70% in Ashkenazi Jewish Gaucher patients Reduced enzyme activity; common in Gaucher type 1
c.1448T>C (p.Leu483Pro) Missense ~30% in non-Jewish Gaucher patients Severe enzyme deficiency; associated with neuronopathic Gaucher
c.84dupG Frameshift Rare Null allele; causes severe Gaucher disease
c.1604G>A (p.Arg535His) Missense ~3% in Parkinson's disease cohorts Moderate loss of function; increases Parkinson's risk
Mutation functional classification

Loss of Function (LOF)

Most GBA1 mutations reduce or eliminate glucocerebrosidase activity, leading to substrate accumulation and lysosomal dysfunction.

Gain of Function (GOF)

Not described for GBA1; no evidence of gain-of-function mutations.

Dominant Negative (DN)

Heterozygous mutations in GBA1 are thought to act via haploinsufficiency or dominant-negative effects on lysosomal function, though the exact mechanism in Parkinson's disease is debated.

Gene Ontology (GO)

• GO:0004348 - glucosylceramidase activity • GO:0005764 - lysosome
• GO:0006680 - glucosylceramide catabolic process • GO:0007040 - lysosomal protein catabolic process
• GO:0016787 - hydrolase activity

Pathways

KEGG: hsa00600 - Sphingolipid metabolism
KEGG: hsa04142 - Lysosome
Reactome: R-HSA-1660662 - Glycosphingolipid metabolism

Protein Summary

Glucocerebrosidase (UniProt P04062) is a 536-amino-acid lysosomal enzyme that cleaves the beta-glucosidic linkage of glucocerebroside. It requires the cofactor saposin C for optimal activity. The protein is synthesized as a precursor and processed in the lysosome. Mutations cause enzyme deficiency, leading to Gaucher disease, and heterozygosity increases Parkinson's disease risk.

Related Products

Product name Cat.No. Species Gene ID
GBA1 Knockout HEK293 Cell Line EDC90036 Human 2629 Details Get a Quote
GBA1 Knockout A-549 Cell Line EDJ-KQ43222 Human 2629 Details Get a Quote
GBA1 Knockout HCT 116 Cell Line EDJ-KQ43223 Human 2629 Details Get a Quote
GBA1 Knockout HeLa Cell Line EDC08301 Human 2629 Details Get a Quote
Displaying Records 1 To 4 Of 4 Records
Contact Us
*
*
*
*
How did you hear about us: